CAS: 627-09-8; Propargylacetate

该化合物是一种有机化合物,其特征是碳基功能组和乙酸盐,其分子配方为C5H8O2,其特征是第一和第二碳原子之间的三联,有助于其再活动.该化合物一般是一种无色液体,有独特的味,在乙醇和乙醇等有机溶剂中溶解,但水溶解性有限.丙基乙酸酯主要用作有机合成的中间体,特别是在制药和农用化学生产中.其活性允许其参与各种化学反应,包括核分裂性添加和聚合过程.安全考虑包括其易燃性和对皮肤和眼睛的潜在刺激作用,需要适当的处理和储存协议.

结构式图片

相似化合物

623-47-2 4341-76-8 1573-17-7

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号107-19-7 丙炔醇 | CAS号75-36-5 乙酰氯 | CAS号64-19-7 冰醋酸 | CAS号108-24-7 乙酸酐 | CAS号6089-04-9 哌喃 | CAS号141-78-6 乙酸乙酯 | CAS号17869-81-7 1-Propyne,3-(me... | CAS号26755-52-2 prop-2-ynyl 2-b... | CAS号74-99-7 丙炔 | CAS号127-09-3 乙酸钠 | CAS号3558-69-8 2,6-二苯基哌啶 | CAS号463-49-0 丙二烯 | CAS号128064-23-3 6-(4-methyl-3H-... | CAS号10453-86-8 苄蚨菊酯 | CAS号13831-30-6 乙酰氧基乙酸 | CAS号35956-47-9 4-morpholin-4-y... | CAS号32933-07-6 ETHANONE, 1-(2,...

合成工艺路线路线简述

    📜Propargyl Monobromoacetate置于2,4,6-三甲基吡啶,二苯甲酮体系中,用 甲醇,异丙醇 作为反应溶剂,以40%的收率获得产物乙酸炔丙酯
    参考文献:Unsaturated Spiro-γ-Lactone Formation By The Dissociative Reduction Of Bromoacetates
    标题:Unsaturated Spiro-γ-Lactone Formation By The Dissociative Reduction Of Bromoacetates
    摘要:Unsaturated Spiro-Gamma-Butyrolactones Can Be Prepared In Good Yields From Bromoacetate Precursors By A Simple Route That Requires Only 2-Propanol As Solvent And Free Radical Initiation.
    DOI:10.1016/s0040-4039(00)97292-7

    海关参考信息

    专利信息


    专利号:US-2003180804-A1
    优先权日:2001-10-29
    标题:Solid phase synthesis of chemical libraries
    发明人:PRYOR KENT E; LEWIS RONALD D; BROWN JASON W
    权利人:CORVAS INT INC
    摘要:The present invention provides compounds and compound libraries that are useful as protease modulators. The compounds and compound libraries are preferably made using the methods of the present invention which utilize peptide synthesis and combinatorial chemistry methods on a solid phase.

    专利号:US-2005119332-A1
    优先权日:1998-03-12
    标 题 :Substituted thiophene compounds as modulators of protein tyrosine phosphatases (PTPases)
    发明人:JEPPESEN LONE; ANDERSEN HENRIK S; OLSEN OLE H; JUDGE LUKE M; HOLSWORTH DANIEL D; BAKIR FARID; AXE FRANK U; GE YU
    摘要:The present invention provides novel compounds of formula 1a, n nnovel compositions, methods of their use, and methods of their manufacture, where such compounds are pharmacologically useful inhibitors of Protein Tyrosine Phosphatases (PTPase's) such as PTP1B, CD45, SHP-1, SHP-2, PTPα, LAR and HePTP or the like. The compounds are useful in the treatment of type I diabetes, type II diabetes, impaired glucose tolerance, insulin resistance, obesity, immune dysfunctions including autoimmunity diseases with dysfunctions of the coagulation system, allergic diseases including asthma, osteoporosis, proliferative disorders including cancer and psoriasis, diseases with decreased or increased synthesis or effects of growth hormone, diseases with decreased or increased synthesis of hormones or cytokines that regulate the release of/or response to growth hormone, diseases of the brain including Alzheimer's disease and schizophrenia, and infectious diseases.

    专利号:US-2002165398-A1
    优先权日:1998-03-12
    标题:Modulators of protein tyrosine phosphatases (PTPases)
    发明人:JEPPESEN LONE; ANDERSEN HENRIK SUNE; OLSEN OLE HVILSTED; JUDGE LUKE MILBURN; HOLSWORTH DANIEL DALE; BAKIR FARID; AXE FRANK URBAN; GE YU
    摘要:The present invention provides novel compounds, novel compositions, methods of their use, and methods of their manufacture, where such compounds are pharmacologically useful inhibitors of Protein Tyrosine Phosphatases (PTPase's) such as PTP1B, CD45, SHP-1, SHP-2, PTPα, LAR and HePTP or the like. n The compounds are useful in the treatment of type I diabetes, type II diabetes, impaired glucose tolerance, insulin resistance, obesity, immune dysfunctions including autoimmunity diseases with dysfunctions of the coagulation system, allergic diseases including asthma, osteoporosis, proliferative disorders including cancer and psoriasis, diseases with decreased or increased synthesis or effects of growth hormone, diseases with decreased or increased synthesis of hormones or cytokines that regulate the release of/or response to growth hormone, diseases of the brain including Alzheimers disease and schizophrenia, and infectious diseases.

    专利号:US-8829184-B2
    优先权日:2010-04-15
    标题:Intermediates useful for the synthesis of pyrrolobenzodiazepines
    发明人:HOWARD PHILIP WILSON; MASTERSON LUKE; TIBERGHIEN ARNAUD
    权利人:HOWARD PHILIP WILSON; MASTERSON LUKE; TIBERGHIEN ARNAUD; SPIROGEN SARL
    摘要:A compound of formula (I): which is substantially free of any of the corresponding compound of formula (IB): methods of making such compounds, and the further transformation of such compounds.

    专利号:US-3635999-A
    优先权日:1969-03-25
    标 题 :Synthesis of oxazoles
    发明人:TRAMIER BERNARD; BONZOM ALBERT
    权利人:AQUITAINE PETROLE
    摘要:WHERE R2 IS ALKYL OF 1 TO 6 CARBON ATOMS, PHENYL OR HYDROXYPHENYL, R4 IS METHYL AND R5 IS HYDROGEN. A PROCESS OF PREPARING OXAZOLES IS DISCLOSED COMPRISING CONDENSING AN ACETYLENIC COMPOUND HAVING AN ELECTRONEGATIVE GROUP ON THE CARBON ATOM IN THE X-POSITION RELATIVE TO THE TRIPLE BOND WITH AN AMMONIUM SALT OF AN ORGANIC ACID OR AN AMIDE. 2-R2,4-R4,5-R5-OXAZOLE NEW OXAZOLES ARE PREPARED HAVING THE FORMULA

    专利号:US-8269047-B2
    优先权日:2009-07-23
    标题 :Synthesis of alpha-halo enones and enals
    发明人:ZHANG LIMING; YE LONGWU
    权利人:ZHANG LIMING; YE LONGWU; UNIV NEVADA
    摘要:A method for preparing an α-halo enal or enone from an unprotected propargyl alcohol and an electrophilic halogen source catalyzed by the combination of a gold catalyst complex and a metal co-catalyst complex is disclosed. The method can be further enhanced by addition of an additive that facilitates suppression of a des-halo derivative.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    参考标题:Synthesis Of Piperidine Derivatives By Rhodium- Catalyzed Tandem Reaction OfN-Sulfonyl-1,2,3-Triazole And Vinyl Ether
    作者:Sisi Yu,Yuehui An,Wenlin Wang,Ze-Feng Xu,Chuan-Ying Li |发布日期:2018.6.5
    摘要:A Chemoselective Tandem Reaction Of 4‐acyloxymethylene‐1‐sulfonyl‐1,2,3‐triazole And Vinyl Ether Was Reported, Producing Polysubstituted Piperidine Derivatives In Up To 96% Yield. The Key Intermediate N‐sulfonyl 1‐azadiene Generated By Migration Of The Oac Group To The α‐imino Rhodium Carbene Was Isolated And A Plausible Mechanism Was Proposed. Several Related Ring Systems Were Constructed From The

    合成参考文献


    摘要:Ohno, H.; Tomioka, K., Science of Synthesis, (2008) 44, 127.
    摘要:Michalak, M.; Gulajski, L.; Grela, K., Science of Synthesis, (2010) 47, 392.
    摘要:Braverman, S.; Cherkinsky, M., Science of Synthesis Knowledge Updates, (2014) 3, 209.
    摘要:Aubert, C.; Malacria, M.; Ollivier, C., Science of Synthesis: Stereoselective Synthesis, (2011) 3, 191.
    摘要:Molteni, G., Science of Synthesis: Water in Organic Synthesis, (2012) 1, 463.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知